-
After Colorectal Cancer, Survivors Face Higher Risk for a Second Cancer
Researchers find increased risk of four types of secondary cancer in patients diagnosed with early-onset colorectal cancer.
by Sandra Gordon
-
Sunscreen Is Just the Start
Experts say protection against UV rays and watching for changes in your skin are important tools in skin cancer risk prevention.
by Kyle Bagenstose
-
Ovarian Cancer: A Quest to Extend Remissions
New treatments aim to lengthen remissions and push back recurrences.
by Erin O’Donnell
-
Survivor Profile
Educator and AdvocateFormer teacher Peggy Zuckerman helps others by sharing her experiences with stage IV kidney cancer.
by Kristin Baird Rattini
-
ADCs Make Their Mark
Antibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.
by Kendall K. Morgan
-
Forward Look
Bispecific Antibodies to Treat CancerHematologist-oncologist Saad Usmani talks about recent approvals for bispecific antibodies to treat multiple myeloma and other blood cancers.
by Ashley P. Taylor
-
Forward Look
New Hormonal Therapy Pill for Advanced Breast CancerNew oral hormonal therapy offers alternative to injections for some women with metastatic disease.
by Kris Conner
-
Forward Look
Tumor-infiltrating LymphocytesAdoptive T-cell therapy shows promise in treating metastatic melanoma.
by Marci A. Landsmann
-
Forward Look
Pausing Treatment for PregnancyYoung women who have had hormone receptor-positive breast cancer can safely suspend endocrine therapy to try to have a child.
by Carolyn Bernhardt
-
Sex and Gender Minorities Face Disparities in Breast Cancer Care
Lesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.
by Jon Kelvey
Cancer Talk
Treatment Combination Improves Survival in EGFR-positive Lung Cancer
Adding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
Lessons From 20 Years Living With CancerMultiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.
by Eric Fitzsimmons
The Enduring Importance of Cancer Disparities ResearchOpening session from AACR conference highlights how perseverance and adversity have informed cancer disparities research over the years.
by Eric Fitzsimmons
Most Cancer Survivors Don’t Meet Healthy Diet GoalsDespite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
